Skip to content
VP

Vysali Pharmaceuticals

524290 BSE
Price unavailable
View as Markdown
MCP

No trades in 1Y

Key Insights

Strengths

2
  • Company has reduced debt.
  • Company's working capital requirements have reduced from 205 days to 147 days

Weaknesses

2
  • Company has low interest coverage ratio.
  • Company might be capitalizing the interest cost

Growth Rate

Annual windows: The latest annual results are more than two years old, so no annual growth is shown.

Trailing twelve months: No quarterly results are reported.

Not shown: Quarterly Results. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

Profit & Loss

₹ Cr
524290 profit and loss, annual, ₹ crore
Particulars Mar 2006Jun 2007 15m
Sales
5
10
Expenses
10
23
Operating Profit
−5
−13
OPM %
−104%
−134%
Other Income
1
26
Interest
0
0
Depreciation
0
0
PBT
−5
12
Tax %
0%
0%
Net Profit
−5
12
Div. Payout %
0%
0%

Balance Sheet

₹ Cr
524290 balance sheet, annual, ₹ crore
Particulars Mar 2006Jun 2007
Equity Capital
5
5
Reserves
−19
6
Borrowings
21
10
Other Liabilities
5
5
Total Liabilities
12
27
Fixed Assets
4
17
CWIP
0
0
Investments
0
0
Other Assets
8
10
Total Assets
12
27

Cash Flow

₹ Cr
524290 cash flow, annual, ₹ crore
Particulars Mar 2006Jun 2007
Operating
—
12
Investing
—
0
Financing
—
−11
Net Cash Flow
—
1
Free Cash Flow
—
12
CFO/OP
—
−93

Ratios

524290 financial ratios, annual
Particulars Mar 2006Jun 2007
Debtor Days
62
71
Inventory Days
565
377
Days Payable
130
108
Cash Conversion Cycle
497
340
Working Capital Days
263
147
ROCE %
—
−2%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vysali Pharmaceuticals insights

24 extracted metrics across FY06–FY26.

Shareholding Pattern

Not shown: Shareholding Pattern. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.

Documents

Frequently Asked Questions about Vysali Pharmaceuticals

Where is Vysali Pharmaceuticals Ltd (524290) listed?
Vysali Pharmaceuticals Ltd trades under code 524290 on the BSE.
Which sector does Vysali Pharmaceuticals Ltd belong to?
Vysali Pharmaceuticals Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524290.md for Vysali Pharmaceuticals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More